Agreement among healthcare professionals in diagnosing case vignette-based surgical site infections in 10 European countries. G. Birgand 1, D. Lepelletier.

Slides:



Advertisements
Similar presentations
Surveillance of nosocomial infections Johnny, Courtesy, Brocolli.
Advertisements

Coronel Institute, Academic Medical Center Amsterdam MODERNET Establishing a European network for monitoring trends in occupational diseases and new and.
European Centre for Disease Prevention and Control
Diabetic Foot Problems
HICC An Infection Control Committee provides a forum for multidisciplinary input and cooperation, and information sharing This committee should include.
Meeting the Challenge of Mandatory HAI Reporting Marcy Maxwell RN, BSN, CIC Dignity Health March 6, 2012.
Outbreak Scenario S. marcescens At a multi-disciplinary meeting on the surgical unit concerns are raised regarding a possible increase in.
Hospital Surveillance. Impact of infectious diseases  IDs are considered to be the leading cause of death  Mass population movement  Emerging and re-emerging.
Investigator Initiated studies Some data from Benchmarking of Clinical trials in Japan 18 Multi-National and Japanese companies benchmarked their clinical.
Health Departments and Healthcare-Associated Infection Prevention Research: A New Land of Opportunity? Matthew Wise, MPH, PhD Epidemiologist, Office of.
Implementation of Safe Clinical Practices Work Package 5 Lena Mehrmann, Tugce Aksoy, Christian Thomeczek German Agency for Quality in Medicine (AQuMed.
Centers of Excellence Monterey Bay Public Employees Trust Centers of Excellence 2014 Centers of Excellence are selected after careful review by.
Report Cards : Assessing the Impacts of the Public Disclosure of Antibiotic Prescribing Rate for Acute Upper Respiratory Tract Infection Seemoon Choi*,
Haluza D (1), Moshammer H (1), Medina S (2), Perez L (3), Forsberg B (4)* (1) Medical University of Vienna, (2) InVS Paris, (3) Swiss TPH, Basel, (4) Umea.
1 Terri Conner,PhD Nybeck Analytics Partnership for Patients 14 th May 2012 USE OF MEDICARE DIAGNOSIS AND PROCEDURE CODES TO IMPROVE DETECTION OF SURGICAL.
The epidemiology of HAI Scotland Dr Jacqui Reilly Consultant Epidemiologist Head of HAI and IC Group.
U N I V E R S I T Ä T S M E D I Z I N B E R L I N Entrustable professional activities for learning in competency-based undergraduate medical education.
Global Pediatric Emergency Poisoning Surveillance System Research in European Paediatric Emergency Medicine (REPEM)
A pilot assessment of the impact and resource implications of a 48-hour ward-based stewardship team review on antibiotic use in a tertiary centre Nicola.
For more information, visit : or contact: Summary PROMOVAX is a 3-year EU-funded project.
The Aga Khan University, Health Sciences Research Assembly March 15-17, 2005 Poster presentation by: Khawaja Mustafa & Azra Qureshi FHS Library, Aga Khan.
The EuroHOPE- project: Comparison of treatment and outcome for AMI and stroke patients in Europe On behalf of the EuroHOPE-team: Terje P. Hagen Department.
TASK FORCE ON WRDs SURVEILLANCE TASK FORCE ON WRDs SURVEILLANCE Monica Francesca Blasi, Paola Meli, Mario Carere, Enzo Funari National Institute of Health.
1 1 The AHRQ Surveys on Patient Safety Culture Setting the Standard for Patient Safety Culture Around the Globe AHRQ Annual Meeting September 19, 2011.
1 Economic and medical adverse effects of a national policy to control the spread of highly-resistant micro-organisms. G Birgand a, M Schwarzinger b, A.
Assuring Data Quality Dept. of Healthcare-Associated Infection & Antimicrobial Resistance, Health Protection Agency Jennie Wilson Programme Leader – SSI.
Infection Prevention and Control Committee (IPCC) Hand Hygiene Program Healthcare Associated Infections (HCAI) Surgical Site Infection (SSI) Surveillance.
CAF Resource Centre at EIPA Open Days Patrick Staes Senior Expert European Institute of Public Administration THE COMMON ASSESSMENT FRAMEWORK.
Intersection of Surgical Outcomes and Medical Education: The ACS Perspective (Division of Research and Optimal Patient Care) Clifford Y. Ko, MD MS MSHS.
Integrated Multidisciplinary Management of Invasive Fungal Infections Dr. Murat Akova Hacettepe University School of Medicine Section of Infcetious Diseases.
One Healthcare System’s Response to the Chaos Swedish Health Services Swedish Medical Centers: Ballard, Cherry Hill, Edmonds, First Hill, & Issaquah Ambulatory.
NHS Benchmarking Data Susan Hamilton Consultant in Public Health South Gloucestershire Council.
2010 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
Study on the Association between having an Effective Health Emergency Response to Leptospirosis and the Presence of a Functionally Prepared Health Emergency.
1 Quality of Care and Patient Safety: Impact on Healthcare January 22, 2009 Presenter: F. Lisa Murtha, Practice Leader and Managing Director, Huron Consulting.
Országos Epidemiológiai Központ National Center for Epidemiology, Budapest, Hungary Activities in Hungary for preventing AMR and controlling HCAI Emese.
Norwegian Financial Mechanism Public Health Programme Area Network of Mental Health Coordinators István Bitter Dept. Psychiatry and Psychotherapy.
An Audit to Determine if Prescribers are Reviewing Antimicrobial Prescriptions Hours After Initiation. Natalie Holman, Emma Cramp, Joy Baruah Hinchingbrooke.
OBJECTIVE INTRODUCTION Emergency Medicine Milestones: Longitudinal Interrater Agreement EM milestones were developed by EM experts for the Accreditation.
Research Center for Insurance Medicine AMC-UMCG-UWV-VUmc The assessment of work endurance in EUMASS member states Henk-Jan Boersema EUMASS congres 2016.
The role of the insurance physician in return to work. An international survey Corina Oancea, Soren Brage, Freddy Falez, Wout de Boer 21 st EUMASS Congress.
Northern Dimension Antibiotic Resistance Study NoDARS Prof Jaana Vuopio, M.D., Ph.D., PAC 11 side-event, 19 November 2015, Berlin, Germany.
Self-taken extragenital samples compared with clinician-taken extragenital samples for the diagnosis of gonorrhoea and chlamydia in women and MSM Janet.
 Overall, mean WS and GS performance improved during hospital stay (Table 2), no significant change was observed in ADL.  Patients with poor physical.
Figure 1. Participation in the surveillance of SSIs, EU/EEA, 2013–2014
An Alternative Certification Examination “ACE”, to assess the domains of professional practice.  Morris M1*, Gillis AE2, Smoothey CO3, Hennessy M1, Conlon.
Orthopaedic SSI Surveillance in BSH Cork
2nd Bench – Can Core Group Meeting Welcome and introduction
Prevalence of potentially inappropriate prescribing in a sub-population of older European clinical trial participants O’ Riordan, D 1; Walsh , K1; Sinnott,
2017 National Patient Safety Goals
Results of the STRUTI project
Experience of using beta-D-glucan assays in the Intensive Care Unit.
Pre-operative surgical scrubs: review of evidence and survey of current practice
GLOBAL POINT PREVALENCE SURVEY
C-SCOPE: Survey on the Management of HCV in addiction clinics treating Patients on Opiate Agonist Therapies: a global perspective July 2017.
Accreditation centers & Training for the trainers
for the RODAM Consortium
Q & A review APIC Greater NY Chapter 13 February 15, 2017 Melissa A
CNISP & CIHI MRSA infection rate comparison Preliminary results
ECDC point prevalence survey (PPS)
Hospital organization, management, and structure for the infection prevention and control of healthcare-associated infection in Chinese hospitals:
Sternal wound infection after cardiac surgery: incidence and risk factors according to clinical presentation  A. Lemaignen, G. Birgand, W. Ghodhbane,
Point prevalence survey epidemiology
Inside COMBACTE network: global information for a global problem.
Sternal wound infection after cardiac surgery: incidence and risk factors according to clinical presentation  A. Lemaignen, G. Birgand, W. Ghodhbane,
Public Health Surveillance
Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes  J. Freeman, J. Vernon, K. Morris, S.
Overuse/Misuse of Surgical Antimicrobial Prophylaxis (SAP) in a Rural Hospital in Uganda Hiroki Saito, MD MPH;1 Kyoko Inoue, MPH;2 James Ditai, MPH;3.
The Heart Truth Delaware Background
I-Chan Lin MD, Paul P. Lee MD, JD
Presentation transcript:

Agreement among healthcare professionals in diagnosing case vignette-based surgical site infections in 10 European countries. G. Birgand 1, D. Lepelletier 2, G. Baron 3, S. Barrett 4, A-C Breier 5, C. Buke 6, L. Markovic-Denic 7, P. Gastmeier 5, J. Kluytmans 8, O. Lyytikainen 9, E. Sheridan 10, E. Szilagyi 11, E. Tacconelli 12, N. Troillet 13, P. Ravaud 3, JC Lucet 1 and the VARSSI study group 1 Infection control unit, Bichat-Claude Bernard Hospital, Paris, France; 2 Hygiene Department, Nantes University Hospital, France; 3 Centre d’Épidémiologie Clinique, Hôpital Hôtel Dieu, Paris, France; 4 Medical microbiology and infection control, Southend Hospital, UK; 5 Institute of Hygiene and Environmental Medicine, Charité - University Medicine Berlin, Germany; 6 Department of Infectious Diseases and Clinical Microbiology, Ege University Medical Faculty, Izmir, Turkey; 7 Institute of epidemiology, Faculty of Medicine, University of Belgrade, Serbia; 8 Medical microbiology and infection control, Amphia medical center Breda, The Netherlands; 9 Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare (THL), Helsinki, Finland; 10 Department of Healthcare-Associated Infection and Antimicrobial Resistance, HPA Centre for Infections, London, UK; 11 Department of Epidemiology, Budapest, Hungary; 12 Department of Infectious Diseases, Università Cattolica del Sacro Cuore, Rome, Italy; 13 Department of infectious diseases, Central Institute, Valais Hospital, Sion, Switzerland.

Disclosure statement Financial support: – French Ministry of Health (national grant PREQHOS 0901) Conflict of interest: – Pfizer: Travel grant for the ICAAC 2011 G Birgand VARSSI study ECCMID Berlin 2013

Background Public reporting of HAI to improve public information and performance: process indicators or infection rates However, SSI rates vary according to several factors – Co-morbidities, contamination class, conditions of the surgical procedure – Robustness of SSI rates depends on definitions, training, and experience Recent studies: – Wilson AP, BMJ 2004: variable interpretations of definitions – French study: disagreement among healthcare professionals in SSI diagnosis using case-vignettes (Lepelletier, Plos one 2012) – European network: large differences in SSI recognition across countries (Wilson J, JHI 2007) G Birgand VARSSI study

Objectives To assess agreement in SSI diagnosis among Infection Control Physicians (ICPs) and surgeons involved in SSI surveillance in 10 European countries - Main objective = intra-country/intra-specialty variability - Secondary objective = intra-specialty/inter-country variability - Criteria n°1: presence/absence of SSI - Criteria n°2: depth To assess the impact of SSI definition availability on diagnosis G Birgand VARSSI study ECCMID Berlin 2013

10 participating countries G Birgand VARSSI study

Methods Elaboration of case vignettes 20 case vignettes built from patients hospitalised in 6 surgical units of 3 French university hospitals – Cardiac (n=5), Digestive (n=5), Orthopedic (n=4), ENT (n=2), Gynecology (n=2) and Neurosurgery (n=2) – Wound discharge and/or infectious signs – Bedside evaluation with collection of biological, bacteriological and radiological signs Case vignettes standardised by the same investigator – Same chronological information – Internet-secured relational database with personal login and password ECCMID Berlin 2013 G Birgand VARSSI study

20 vignettes 10 ICPs x 8 vignettes 10 Surgeons x 8 vignettes 20 x 4 = 80 readings per specialty 160 readings per country X10 countries 1600 readings

No SSISSI SSI certainly absent SSI certainly present Existence of SSI Intra-class correlation coefficient (ICC) with 95%CI Methods G Birgand VARSSI study ECCMID Berlin 2013

No SSISSI SSI certainly absent SSI certainly present Superficial SSI Deep or organ/space SSI Don’t know Existence of SSI Intra-class correlation coefficient (ICC) with 95%CI Depth of SSI kappa coefficient (kC) with 95%CI Methods G Birgand VARSSI study

Methods Interpretation of agreement Intra-correlation coefficient (presence/absence of SSI) – < 0.40= poor agreement – = good agreement – > 0.71= excellent agreement Kappa coefficient (SSI depth) – < 0.40= poor agreement – = fair agreement – = good agreement – > 0.81= excellent agreement Landis JR. Biometrics 1977 Nunnally JC. Psychometric theory 1994 G Birgand VARSSI study ECCMID Berlin 2013

Number of participants 10 ICPs + 10 Surgeons 10 ICPs + 4 Surgeons 10 ICPs + 9 Surgeons 100 ICPs and 86 Surgeons G Birgand VARSSI study

Results Assessment of agreement about SSI diagnosis G Birgand VARSSI study Intra-country correlation N SSI diagnosis scoring, 7-point Likert scale Intra-correlation coefficient ICC ICP Turkey Serbia Hungary Italy Germany Finland Netherlands Switzerland France UK Inter-country

G Birgand VARSSI study Results Assessment of agreement about SSI diagnosis Intra-country correlation N SSI diagnosis scoring, 7-point Likert scale Intra-correlation coefficient ICC ICPSurgeons Turkey Serbia Hungary Italy Germany Finland Netherlands Switzerland France UK Inter-country

Intra-country correlation N SSI diagnosis scoring, 7-point Likert scale Intra-correlation coefficient ICC ICPSurgeonsAll Turkey Serbia Hungary Italy Germany Finland Netherlands Switzerland France UK Inter-country G Birgand VARSSI study Results Assessment of agreement about SSI diagnosis No impact of definition on the agreement between participants regarding the presence of SSI

Results Assessment of agreement about SSI depth G Birgand VARSSI study Countries SSI depth, 4-point scale (Kappa coefficient) ICP Turkey 0.26 Serbia 0.05 Hungary 0.20 Italy 0.23 Germany 0.50 Finland 0.27 Netherlands 0.25 Switzerland 0.34 France 0.44 UK 0.38 Inter-country 0.28

Results Assessment of agreement about SSI depth G Birgand VARSSI study Countries SSI depth, 4-point scale (Kappa coefficient) ICPSurgeons Turkey Serbia 0.05 Hungary Italy Germany Finland Netherlands Switzerland France UK Inter-country

Countries SSI depth, 4-point scale (Kappa coefficient) ICPSurgeonsAll Turkey Serbia Hungary Italy Germany Finland Netherlands Switzerland France UK Inter-country Results Assessment of agreement about SSI depth G Birgand VARSSI study No impact of definition on the agreement between participants regarding SSI depth

Discussion Large disagreement among healthcare professionals in SSI diagnosis: – varied both between and within specialties  need for a multidisciplinary approach One country (Germany) with the best agreement – Regular cross-hospital evaluation of diagnosis accuracy through surveillance network Limitations: – SSI diagnosis made by individuals without teamwork – Scoring via an online database without contact with patients – Selection bias (recruitment by European leaders of participants presumed to be expert on this topic) G Birgand VARSSI study

Conclusion Original approach to assess the variability of SSI diagnosis – Large panel of ICPs and surgeons in 10 European countries SSI rates should be used with caution for benchmarking or public reporting SSI surveillance and feedback remain important tools for SSI prevention – Further studies are needed to improve agreement regarding the SSI diagnosis G Birgand VARSSI study ECCMID Berlin 2013

Aknowledgment The VARSSI study group: –Turkish, Finnish, Hungarian, German, Italian, Serbian, Swiss, Duch, British and French ICPs and Surgeons participants Participating wards: –Pr Nataf, Cardiac surgery, Pr Marmuse, Digestive surgery; Pr Massin, Orthopedic surgery, Bichat- Claude Bernard University Hospital –Pr Despins, Cardiac Surgery, University Hospital, Nantes; G Birgand VARSSI study ECCMID Berlin 2013

Thank you for your attention

Results Distribution of scores CountriesN Infect Contr PhysSurgeons Median (IQR) Turkey (4 - 7)7 (4 - 7) Serbia (3 - 7) 6 (3 - 7) Hungary (4 - 7) 7 (3 - 7) Italy (4 - 7) 6 (3 - 7) Germany ( ) 6 (3 - 7) Finland (3 - 7) Netherlands (3 - 7) 6 (4 - 7) Switzerland ( ) 7 (6 - 7) France (3 - 7) 5 (2 - 7) UK (4 - 7) 6 ( ) Total (4 - 7) 6 (3 - 7) G Birgand VARSSI study

Results Distribution of scores CountriesN Infect Contr PhysSurgeons Median (IQR)Min-MaxMedian (IQR)Min-Max Turkey ·0 (4·0-7·0)1·0-7·07·0 (4·0-7·0)1·0-7·0 Serbia ·0 (3·0-7·0)1·0-7·0 6·0 (3·0-7·0)1·0-7·0 Hungary ·0 (4·0-7·0)1·0-7·0 7·0 (3·0-7·0)1·0-7·0 Italy ·0 (4·0-7·0)1·0-7·0 6·0 (3·0-7·0)1·0-7·0 Germany ·0 (3·5-7·0)1·0-7·0 6·0 (3·0-7·0)1·0-7·0 Finland ·0 (3·0-7·0)1·0-7·0 6·0 (3·0-7·0)1·0-7·0 Netherlands ·0 (3·0-7·0)1·0-7·0 6·0 (4·0-7·0)2·0-7·0 Switzerland ·0 (4·5-7·0)1·0-7·0 7·0 (6·0-7·0)1·0-7·0 France ( )1·0-7·0 5.0 ( )1·0-7·0 UK ·0 (4·0-7·0)1·0-7·0 6·0 (4·5-7·0)1·0-7·0 Total1488 6·0 (4·0-7·0)1·0-7·0 6·0 (3·0-7·0)1·0-7·0 G Birgand VARSSI study

Intra-country correlation N SSI diagnosis scoring, 7-point Likert scale Intra-correlation coefficient ICC ICP Spontaneous scoring Surgeons Spontaneous scoring All Spontaneous scoring Turkey ·44 (0·22-0·68) 0·23 (0·03-0·50) Serbia ·26 (0·05-0·53)0·06 (0·00-0·35) 0·20 (0·04-0·41) Hungary ·28 (0·07-0·54)0·24 (0·04-0·51)0·31 (0·16-0·54) Italy ·31 (0·10-0·57)0·08 (0·00-0·36) 0·20 (0·07-0·42) Germany ·65 (0·45-0·82)0·46 (0·23-0·69)0·55 (0·37-0·74) Finland ·30 (0·09-0·57)0·21 (0·01-0·48) 0·30 (0·15-0·52) Netherlands ·45 (0·23-0·69)0·00 (0·00-0·35)0·42 (0·23-0·65) Switzerland ·40 (0·18-0·65)0·08 (0·00-0·34)0·26 (0·12-0·48) France ·44 (0·22-0·68)0·30 (0·07-0·57) 0·41 (0·24-0·63) UK ·59 (0·38-0·80)0·04 (0·00-0·62) Inter-country1488 0·41 (0·28-0·61)0·24 (0·14-0·42) G Birgand VARSSI study Results Assessment of agreement about SSI diagnosis

Countries SSI depth, 4-point scale (Kappa coefficient) Not scored ICP Not scored Surgeons Not scored All Turkey 190·26 (0·21-0·31) 170·25 (0·20-0·30) 360·27 (0·24-0·30) Serbia 210·05 (0·00-0·10)250·05 (0·00-0·10)460·09 (0·07-0·11) Hungary 180·20 (0·15-0·25)220·16 (0·10-0·22)400·19 (0·16-0·22) Italy 210·23 (0·17-0·29)230·09 (0·01-0·17)440·31 (0·18-0·34) Germany 200·50 (0·45-0·55)210·31 (0·26-0·36)410·35 (0·32-0·38) Finland 240·27 (0·22-0·32)230·14 (0·09-0·19)470·25 (0·22-0·28) Netherlands 230·25 (0·20-0·30)70·17 (0·00-0·34)300·25 (0·18-0·32) Switzerland 110·34 (0·28-0·40)180·14 (0·08-0·20)290·24 (0·21-0·27) France 210·44 (0·39-0·49)270·17 (0·09-0·25)480·27 (0·23-0·31) UK 200·38 (0·32-0·44)60·19 (-0·02-0·40)260·34 (0·25-0·42) Inter-country 1980·28 (0·27-0·29)1890·19 (0·17-0·21)-- Results Assessment of agreement about SSI depth G Birgand VARSSI study